Good morning. Today's lecture concerns CRISPR-Cas9, a revolutionary gene-editing technology transforming genetic engineering.  Prior to CRISPR, gene editing was a laborious process, relying on techniques like zinc-finger nucleases and TALENs, which were both expensive and technically challenging.  CRISPR, however, leverages a naturally occurring bacterial defense mechanism.  Bacteria utilize CRISPR sequences to identify and destroy invading viral DNA.  Scientists adapted this system, using a guide RNA molecule to direct the Cas9 enzyme, a molecular scissor, to a specific target DNA sequence.  This allows for precise gene disruption, insertion, or replacement.

The initial discovery of CRISPR systems occurred in the late 1980s, with the mechanism elucidated in the early 2000s.  However, the application of CRISPR-Cas9 as a programmable gene-editing tool rapidly emerged in the early 2010s, catalyzing a surge in research across various fields.  Its relative simplicity and efficiency have made CRISPR a pivotal tool in biomedical research, agricultural biotechnology, and potentially even human gene therapy, albeit with ongoing ethical considerations.  Further advancements continue to refine the precision and scope of CRISPR technology.